Hyperkalemia classification: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
(Created page with "__NOTOC__ {{Hyperkalemia }} {{CMG}}; {{AE}} ==Overview== There is no established system for the classification of [disease name]. OR [Disease name] may be classified accor...")
 
No edit summary
 
(22 intermediate revisions by 3 users not shown)
Line 2: Line 2:
{{Hyperkalemia }}
{{Hyperkalemia }}


{{CMG}}; {{AE}}  
{{CMG}}; {{AE}}{{JSS}}; {{Hudakarman}}
==Overview==
==Overview==
There is no established system for the classification of [disease name].
Hyperkalemia develops when blood [[potassium]] levels are more than 5.1 meq/L. Hyperkalemia can be classified based on the [[potassium]] levels, duration of onset and the cause of hyperkalemia.
== Classification ==
* Hyperkalemia may be classified according to the [[potassium]] levels as : <ref name="pmid21181208">{{cite journal| author=Lehnhardt A, Kemper MJ| title=Pathogenesis, diagnosis and management of hyperkalemia. | journal=Pediatr Nephrol | year= 2011 | volume= 26 | issue= 3 | pages= 377-84 | pmid=21181208 | doi=10.1007/s00467-010-1699-3 | pmc=3061004 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21181208  }} </ref><ref name="pmid7025622">{{cite journal| author=Adrogué HJ, Madias NE| title=Changes in plasma potassium concentration during acute acid-base disturbances. | journal=Am J Med | year= 1981 | volume= 71 | issue= 3 | pages= 456-67 | pmid=7025622 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7025622  }} </ref>
**Mild- [[potassium]] levels between 5.1-6.0 mEq/L.
**Moderate- [[potassium]] levels between 6.1-7.0 mEq/L.
**Severe- [[potassium]] levels more than 7.0 mEq/L.
* Hyperkalemia can be classified on the basis of duration as <ref name="pmid3344745">{{cite journal| author=Magner PO, Robinson L, Halperin RM, Zettle R, Halperin ML| title=The plasma potassium concentration in metabolic acidosis: a re-evaluation. | journal=Am J Kidney Dis | year= 1988 | volume= 11 | issue= 3 | pages= 220-4 | pmid=3344745 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3344745  }} </ref> :
**Hyperacute- develops in a few hours, usually in tissue breakdown or parenteral [[potassium]] supplement.
**[[Acute]]-develops within 48 hours, could be due to [[acute kidney injury]].
**[[Chronic]]-develops gradually, usually due to [[chronic diseases]] such [[Chronic kidney disease|as chronic kidney disease]].<ref name="pmid18638465">{{cite journal| author=Lee HK, Brough TJ, Curtis MB, Polito FA, Yeo KT| title=Pseudohyperkalemia--is serum or whole blood a better specimen type than plasma? | journal=Clin Chim Acta | year= 2008 | volume= 396 | issue= 1-2 | pages= 95-6 | pmid=18638465 | doi=10.1016/j.cca.2008.06.022 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18638465  }} </ref>


OR
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center"
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF| Hyperkalemia classification type}}
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF| Characterestics}}
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" rowspan="6;" |Based on [[potassium]] levels
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" rowspan="1;"|Mild
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Potassium]] levels between 5.1-6.0 mEq/L.


[Disease name] may be classified according to [classification method] into [number] subtypes/groups: [group1], [group2], [group3], and [group4].
*
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" rowspan="1;"|Moderate
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Potassium]] levels between 6.1-7.0 mEq/L.


OR
*
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" rowspan="1;"|Severe
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Potassium]] levels more than 7.0 mEq/L.


[Disease name] may be classified into [large number > 6] subtypes based on [classification method 1], [classification method 2], and [classification method 3].
*
[Disease name] may be classified into several subtypes based on [classification method 1], [classification method 2], and [classification method 3].
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" rowspan="6;" |Based on the duration
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" rowspan="1;"|Hyperacute
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
* Develops in a few hours
* Usually due to  tissue breakdown
* Or due to parenteral [[potassium]] supplement.


OR
*
 
|-
Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" rowspan="1;"|Acute
 
|-
OR
| style="padding: 5px 5px; background: #F5F5F5;" |
 
* Develops within 48 hours,
If the staging system involves specific and characteristic findings and features:
* Could be due to [[acute kidney injury]].
According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
|-
 
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" rowspan="1;"|Chronic
OR
|-
 
| style="padding: 5px 5px; background: #F5F5F5;" |
The staging of [malignancy name] is based on the [staging system].
* Develops gradually,
 
* Usually due to [[chronic diseases]] such [[Chronic kidney disease|as chronic kidney disease]]
OR
|-
 
|}
There is no established system for the staging of [malignancy name].
 
==Classification==
 
There is no established system for the classification of [disease name].
 
OR
 
[Disease name] may be classified according to [classification method] into [number] subtypes/groups:  
*[Group1]
*[Group2]
*[Group3]
*[Group4]
 
OR
 
[Disease name] may be classified into [large number > 6] subtypes based on:  
*[Classification method 1]
*[Classification method 2]
*[Classification method 3]
 
[Disease name] may be classified into several subtypes based on:
*[Classification method 1]
*[Classification method 2]
*[Classification method 3]
 
OR
 
Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
 
OR
 
'''If the staging system involves specific and characteristic findings and features:'''
 
According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
 
OR
 
The staging of [malignancy name] is based on the [staging system].
 
OR
 
There is no established system for the staging of [malignancy name].


==References==
==References==

Latest revision as of 21:15, 22 April 2020

Hyperkalemia Microchapters

Home

Patient information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hyperkalemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural history, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hyperkalemia classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hyperkalemia classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hyperkalemia classification

CDC on Hyperkalemia classification

Hyperkalemia classification in the news

Blogs on Hyperkalemia classification

Directions to Hospitals Treating Hyperkalemia

Risk calculators and risk factors for Hyperkalemia classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Jogeet Singh Sekhon, M.D. [2]; Huda A. Karman, M.D.

Overview

Hyperkalemia develops when blood potassium levels are more than 5.1 meq/L. Hyperkalemia can be classified based on the potassium levels, duration of onset and the cause of hyperkalemia.

Classification

Hyperkalemia classification type Characterestics
Based on potassium levels Mild
Potassium levels between 5.1-6.0 mEq/L.
Moderate
Potassium levels between 6.1-7.0 mEq/L.
Severe
Potassium levels more than 7.0 mEq/L.
Based on the duration Hyperacute
  • Develops in a few hours
  • Usually due to tissue breakdown
  • Or due to parenteral potassium supplement.
Acute
Chronic

References

  1. ↑ Lehnhardt A, Kemper MJ (2011). "Pathogenesis, diagnosis and management of hyperkalemia". Pediatr Nephrol. 26 (3): 377–84. doi:10.1007/s00467-010-1699-3. PMC 3061004. PMID 21181208.
  2. ↑ Adrogué HJ, Madias NE (1981). "Changes in plasma potassium concentration during acute acid-base disturbances". Am J Med. 71 (3): 456–67. PMID 7025622.
  3. ↑ Magner PO, Robinson L, Halperin RM, Zettle R, Halperin ML (1988). "The plasma potassium concentration in metabolic acidosis: a re-evaluation". Am J Kidney Dis. 11 (3): 220–4. PMID 3344745.
  4. ↑ Lee HK, Brough TJ, Curtis MB, Polito FA, Yeo KT (2008). "Pseudohyperkalemia--is serum or whole blood a better specimen type than plasma?". Clin Chim Acta. 396 (1–2): 95–6. doi:10.1016/j.cca.2008.06.022. PMID 18638465.

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Hyperkalemia_classification&oldid=1605908"